Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (15)

2023

  1. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30

  2. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)

    Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60

2021

  1. Evolution of antibody titres against Epstein–Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients

    Scientific Reports, Vol. 11, Núm. 1

2019

  1. Review of the novelties presented at the 2018 ECTRIMS congress: 11th post-ECTRIMS meeting (II)

    Revista de Neurologia, Vol. 68, Núm. 11, pp. 468-479

  2. Review of the novelties presented at the 2018 ectrims congress: 11th post-ectrims meeting (I)

    Revista de Neurologia, Vol. 68, Núm. 10, pp. 431-441

2017

  1. Multimarker risk stratification approach at multiple sclerosis onset

    Clinical Immunology, Vol. 181, pp. 43-50

  2. Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)

    Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84

  3. Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)

    Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40

2015

  1. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

    Annals of Neurology, Vol. 77, Núm. 3, pp. 447-457

2014

  1. Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis

    Annals of Neurology, Vol. 76, Núm. 2, pp. 231-240

2011

  1. Spanish multi-centre observational study of the first attacks suggestive of multiple sclerosis: The PREM cohort

    Revista de Neurologia, Vol. 53, Núm. 10, pp. 577-583

  2. Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice

    Journal of Immunological Methods, Vol. 371, Núm. 1-2, pp. 170-173

2010

  1. IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study

    Clinical Immunology, Vol. 134, Núm. 2, pp. 148-157

2009

  1. Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells. Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudinal study

    Journal of Neuroimmunology, Vol. 212, Núm. 1-2, pp. 112-120

2007

  1. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis

    Journal of Neuroimmunology, Vol. 182, Núm. 1-2, pp. 204-211